Silo Pharma Enters Material Definitive Agreement
Ticker: SILO · Form: 8-K · Filed: May 16, 2025 · CIK: 1514183
| Field | Detail |
|---|---|
| Company | Silo Pharma, Inc. (SILO) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, company-name-change
TL;DR
Silo Pharma just signed a big deal, details TBD.
AI Summary
On May 15, 2025, Silo Pharma, Inc. entered into a material definitive agreement. The company, formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations industry. The filing does not disclose specific details of the agreement or any associated dollar amounts.
Why It Matters
This filing indicates a significant new development for Silo Pharma, Inc., potentially impacting its business operations and future prospects.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, but lacks specific details, creating uncertainty about the nature and impact of the agreement.
Key Players & Entities
- Silo Pharma, Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Pharmaceutical Preparations (industry) — Standard Industrial Classification
- Uppercut Brands, Inc. (company) — Former company name
- Point Capital, Inc. (company) — Former company name
- Gold Swap Inc (company) — Former company name
- 677 N. Washington Boulevard (address) — Principal executive office address
- Sarasota, FL 34236 (address) — Principal executive office address
FAQ
What is the nature of the material definitive agreement entered into by Silo Pharma, Inc. on May 15, 2025?
The filing states that Silo Pharma, Inc. entered into a material definitive agreement on May 15, 2025, but does not provide specific details about the agreement itself.
What was Silo Pharma, Inc. previously known as?
Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc.
In which state is Silo Pharma, Inc. incorporated?
Silo Pharma, Inc. is incorporated in Nevada.
What is Silo Pharma, Inc.'s Standard Industrial Classification code and industry?
Silo Pharma, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the address of Silo Pharma, Inc.'s principal executive offices?
The address of Silo Pharma, Inc.'s principal executive offices is 677 N. Washington Boulevard, Sarasota, FL 34236.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding Silo Pharma, Inc. (SILO).